Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
Washington University School of Medicine
Ratio Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Novartis
Kivu Bioscience Inc.
Baylor College of Medicine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
ViroMissile, Inc.
M.D. Anderson Cancer Center
Institut Bergonié
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
CEBIOTEX
EMD Serono
H. Lee Moffitt Cancer Center and Research Institute
MacroGenics
Wake Forest University Health Sciences
Avacta Life Sciences Ltd
City of Hope Medical Center
Baylor College of Medicine
The Netherlands Cancer Institute
Solve Therapeutics
Baylor College of Medicine
University of Florida
Washington University School of Medicine
University of Southern California
M.D. Anderson Cancer Center
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
University of Rochester
University Health Network, Toronto
University Health Network, Toronto
HiFiBiO Therapeutics
Seattle Children's Hospital
Seattle Children's Hospital
Children's Hospital of Philadelphia
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Washington University School of Medicine
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
M.D. Anderson Cancer Center
Moonshot Antibodies
Valo Therapeutics Oy
Epkin